PEDICA, FEDERICA
PEDICA, FEDERICA
Facoltà di Medicina e Chirurgia
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations
2022-01-01 Guzzeloni, V.; Veschini, L.; Pedica, F.; Ferrero, E.; Ferrarini, M.
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger?
2024-01-01 Gallina, GABRIELE DOMENICO; Gobbin, Giovanni; D’Aliberti, Teresa; Ronzoni, Luisa; Valenti, Luca; Pedica, Federica
A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse
2013-01-01 Pedica, F.; Ruzzenente, A.; Bagante, F.; Capelli, P.; Cataldo, I.; Pedron, S.; Iacono, C.; Chilosi, M.; Scarpa, A.; Brunelli, M.; Tomezzoli, A.; Martignoni, G.; Guglielmi, A.
Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging
2024-01-01 Marchese, A.; Filipello, F.; Cicinelli, M. V.; Sanvito, F.; Pedica, F.; Bandello, F.; Modorati, G.; Miserocchi, E.
Age influence on mice lung tissue response to Aspergillus fumigatus chronic exposure
2015-01-01 Lemieszek, M. K.; Dutkiewicz, J.; Golec, M.; Chilosi, M.; Skorska, C.; Huaux, F.; Pastena, C.; Pedica, F.; Sitkowska, J.; Lisowska, W.; Cholewa, G.; Zwolinski, J.; Mackiewicz, B.; Gora-Florek, A.; Ziesche, R.; Milanowski, J.
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
2023-01-01 Zeng, Qinghe; Klein, Christophe; Caruso, Stefano; Maille, Pascale; S Allende, Daniela; Mínguez, Beatriz; Iavarone, Massimo; Ningarhari, Massih; Casadei-Gardini, Andrea; Pedica, Federica; Rimini, Margherita; Perbellini, Riccardo; Boulagnon-Rombi, Camille; Heurgué, Alexandra; Maggioni, Marco; Rela, Mohamed; Vij, Mukul; Baulande, Sylvain; Legoix, Patricia; Lameiras, Sonia; study group, theHCC-AI; Bruges, Léa; Gnemmi, Viviane; Nault, Jean-Charles; Campani, Claudia; Rhee, Hyungjin; Nyun Park, Young; Iñarrairaegui, Mercedes; Garcia-Porrero, Guillermo; Argemi, Josepmaria; Sangro, Bruno; D'Alessio, Antonio; Scheiner, Bernhard; James Pinato, David; Pinter, Matthias; Paradis, Valérie; Beaufrère, Aurélie; Peter, Simon; Rimassa, Lorenza; Di Tommaso, Luca; Vogel, Arndt; Michalak, Sophie; Boursier, Jérôme; Loménie, Nicolas; Ziol, Marianne; Calderaro, Julien
Association of IgG4-related disease and systemic rheumatic disorders
2023-01-01 Batani, V.; Lanzillotta, M.; Mahajne, J.; Pedica, F.; Palumbo, D.; Venturini, E.; Mapelli, P.; Bossi, P.; Dagna, L.; Emanuel, D. -T.
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis
2022-01-01 Rimini, M; Rimassa, L; Ueshima, K; Burgio, V; Shigeo, S; Tada, T; Suda, G; Yoo, C; Cheon, J; Pinato, D J; Lonardi, S; Scartozzi, M; Iavarone, M; Di Costanzo, G G; Marra, F; Soldà, C; Tamburini, E; Piscaglia, F; Masi, G; Cabibbo, G; Foschi, F G; Silletta, M; Pressiani, T; Nishida, N; Iwamoto, H; Sakamoto, N; Ryoo, B-Y; Chon, H J; Claudia, F; Niizeki, T; Sho, T; Kang, B; D'Alessio, A; Kumada, T; Hiraoka, A; Hirooka, M; Kariyama, K; Tani, J; Atsukawa, M; Takaguchi, K; Itobayashi, E; Fukunishi, S; Tsuji, K; Ishikawa, T; Tajiri, K; Ochi, H; Yasuda, S; Toyoda, H; Ogawa, C; Nishimur, T; Hatanaka, T; Kakizaki, S; Shimada, N; Kawata, K; Tanaka, T; Ohama, H; Nouso, K; Morishita, A; Tsutsui, A; Nagano, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Naganuma, A; Koizumi, Y; Nakamura, S; Joko, K; Iijima, H; Hiasa, Y; Pedica, F; De Cobelli, F; Ratti, F; Alrighetti, L; Kudo, M; Cascinu, S; Casadei-Gardini, A
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib
2022-01-01 Lazzari, C.; Pecciarini, L.; Doglioni, C.; Pedica, F.; Gajate, A. M. S.; Bulotta, A.; Gregorc, V.; Cangi, M. G.
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease
2009-01-01 Pedica, F.; Pecori, S.; Vergine, M.; Brunelli, M.; Montagna, L.; Pedron, S.; Parolini, C.; Daniele, I.; Capelli, P.; Menestrina, F.; Chilosi, M.
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome
2020-01-01 Di Filippo, L.; Vitali, G.; Taccagni, G.; Pedica, F.; Guaschino, G.; Bosi, E.; Martinenghi, S.
Cholangiocarcinoma: new perspectives for new horizons
2021-01-01 Rimini, Margherita; Puzzoni, Marco; Pedica, Federica; Silvestris, Nicola; Fornaro, Lorenzo; Aprile, Giuseppe; Loi, Eleonora; Brunetti, Oronzo; Vivaldi, Caterina; Simionato, Francesca; Zavattari, Patrizia; Scartozzi, Mario; Burgio, Valentina; Ratti, Francesca; Aldrighetti, Luca; Cascinu, Stefano; Casadei-Gardini, Andrea
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients
2023-01-01 Rimini, M.; Fabregat-Franco, C.; Persano, M.; Burgio, V.; Bergamo, F.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Rizzato, M.; Nichetti, F.; Lai, E.; Cappetta, A.; Macarulla, T.; Fassan, M.; De Braud, F.; Pretta, A.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A.
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions
2022-01-01 Macias, R. I. R.; Cardinale, V.; Kendall, T. J.; Avila, M. A.; Guido, M.; Coulouarn, C.; Braconi, C.; Frampton, A. E.; Bridgewater, J.; Overi, D.; Pereira, S. P.; Rengo, M.; Kather, J. N.; Lamarca, A.; Pedica, F.; Forner, A.; Valle, J. W.; Gaudio, E.; Alvaro, D.; Banales, J. M.; Carpino, G.
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection
2022-01-01 Ravaglia, C.; Doglioni, C.; Chilosi, M.; Piciucchi, S.; Dubini, A.; Rossi, G.; Pedica, F.; Puglisi, S.; Donati, L.; Tomassetti, S.; Poletti, V.
Clinicopathological features of adenosquamous pancreatic cancer
2011-01-01 Regi, P.; Butturini, G.; Malleo, G.; Pedica, F.; D'Onofrio, M.; Bassi, C.
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations
2023-01-01 Ahmed, Naghia; Falcinelli, Francesca; Rimini, Margherita; Burgio, Valentina; Casadei-Gardini, Andrea; Aldrighetti, Luca; Ratti, Francesca; Pedica, Federica
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas
2019-01-01 Zaccari, P; Cardinale, V; Severi, C; Pedica, F; Carpino, G; Gaudio, E; Doglioni, C; Petrone, Mc; Alvaro, D; Arcidiacono, P. G.; Capurso, G.
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy?
2023-01-01 Marino, R; Ratti, F; Della Corte, A; Santangelo, D; Clocchiatti, L; Canevari, C; Magnani, P; Pedica, F; Casadei-Gardini, A; De Cobelli, F; Aldrighetti, L
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)]
2022-01-01 Rimini, M.; Macarulla, T.; Burgio, V.; Lonardi, S.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Nappo, F.; Nichetti, F.; Lai, E.; Valgiusti, M.; Cappetta, A.; Fabregat-Franco, C.; Fassan, M.; De Braud, F.; Puzzoni, M.; Frassineti, G. L.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations | 1-gen-2022 | Guzzeloni, V.; Veschini, L.; Pedica, F.; Ferrero, E.; Ferrarini, M. | |
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger? | 1-gen-2024 | Gallina, GABRIELE DOMENICO; Gobbin, Giovanni; D’Aliberti, Teresa; Ronzoni, Luisa; Valenti, Luca; Pedica, Federica | |
A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse | 1-gen-2013 | Pedica, F.; Ruzzenente, A.; Bagante, F.; Capelli, P.; Cataldo, I.; Pedron, S.; Iacono, C.; Chilosi, M.; Scarpa, A.; Brunelli, M.; Tomezzoli, A.; Martignoni, G.; Guglielmi, A. | |
Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging | 1-gen-2024 | Marchese, A.; Filipello, F.; Cicinelli, M. V.; Sanvito, F.; Pedica, F.; Bandello, F.; Modorati, G.; Miserocchi, E. | |
Age influence on mice lung tissue response to Aspergillus fumigatus chronic exposure | 1-gen-2015 | Lemieszek, M. K.; Dutkiewicz, J.; Golec, M.; Chilosi, M.; Skorska, C.; Huaux, F.; Pastena, C.; Pedica, F.; Sitkowska, J.; Lisowska, W.; Cholewa, G.; Zwolinski, J.; Mackiewicz, B.; Gora-Florek, A.; Ziesche, R.; Milanowski, J. | |
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study | 1-gen-2023 | Zeng, Qinghe; Klein, Christophe; Caruso, Stefano; Maille, Pascale; S Allende, Daniela; Mínguez, Beatriz; Iavarone, Massimo; Ningarhari, Massih; Casadei-Gardini, Andrea; Pedica, Federica; Rimini, Margherita; Perbellini, Riccardo; Boulagnon-Rombi, Camille; Heurgué, Alexandra; Maggioni, Marco; Rela, Mohamed; Vij, Mukul; Baulande, Sylvain; Legoix, Patricia; Lameiras, Sonia; study group, theHCC-AI; Bruges, Léa; Gnemmi, Viviane; Nault, Jean-Charles; Campani, Claudia; Rhee, Hyungjin; Nyun Park, Young; Iñarrairaegui, Mercedes; Garcia-Porrero, Guillermo; Argemi, Josepmaria; Sangro, Bruno; D'Alessio, Antonio; Scheiner, Bernhard; James Pinato, David; Pinter, Matthias; Paradis, Valérie; Beaufrère, Aurélie; Peter, Simon; Rimassa, Lorenza; Di Tommaso, Luca; Vogel, Arndt; Michalak, Sophie; Boursier, Jérôme; Loménie, Nicolas; Ziol, Marianne; Calderaro, Julien | |
Association of IgG4-related disease and systemic rheumatic disorders | 1-gen-2023 | Batani, V.; Lanzillotta, M.; Mahajne, J.; Pedica, F.; Palumbo, D.; Venturini, E.; Mapelli, P.; Bossi, P.; Dagna, L.; Emanuel, D. -T. | |
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis | 1-gen-2022 | Rimini, M; Rimassa, L; Ueshima, K; Burgio, V; Shigeo, S; Tada, T; Suda, G; Yoo, C; Cheon, J; Pinato, D J; Lonardi, S; Scartozzi, M; Iavarone, M; Di Costanzo, G G; Marra, F; Soldà, C; Tamburini, E; Piscaglia, F; Masi, G; Cabibbo, G; Foschi, F G; Silletta, M; Pressiani, T; Nishida, N; Iwamoto, H; Sakamoto, N; Ryoo, B-Y; Chon, H J; Claudia, F; Niizeki, T; Sho, T; Kang, B; D'Alessio, A; Kumada, T; Hiraoka, A; Hirooka, M; Kariyama, K; Tani, J; Atsukawa, M; Takaguchi, K; Itobayashi, E; Fukunishi, S; Tsuji, K; Ishikawa, T; Tajiri, K; Ochi, H; Yasuda, S; Toyoda, H; Ogawa, C; Nishimur, T; Hatanaka, T; Kakizaki, S; Shimada, N; Kawata, K; Tanaka, T; Ohama, H; Nouso, K; Morishita, A; Tsutsui, A; Nagano, T; Itokawa, N; Okubo, T; Arai, T; Imai, M; Naganuma, A; Koizumi, Y; Nakamura, S; Joko, K; Iijima, H; Hiasa, Y; Pedica, F; De Cobelli, F; Ratti, F; Alrighetti, L; Kudo, M; Cascinu, S; Casadei-Gardini, A | |
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib | 1-gen-2022 | Lazzari, C.; Pecciarini, L.; Doglioni, C.; Pedica, F.; Gajate, A. M. S.; Bulotta, A.; Gregorc, V.; Cangi, M. G. | |
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease | 1-gen-2009 | Pedica, F.; Pecori, S.; Vergine, M.; Brunelli, M.; Montagna, L.; Pedron, S.; Parolini, C.; Daniele, I.; Capelli, P.; Menestrina, F.; Chilosi, M. | |
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome | 1-gen-2020 | Di Filippo, L.; Vitali, G.; Taccagni, G.; Pedica, F.; Guaschino, G.; Bosi, E.; Martinenghi, S. | |
Cholangiocarcinoma: new perspectives for new horizons | 1-gen-2021 | Rimini, Margherita; Puzzoni, Marco; Pedica, Federica; Silvestris, Nicola; Fornaro, Lorenzo; Aprile, Giuseppe; Loi, Eleonora; Brunetti, Oronzo; Vivaldi, Caterina; Simionato, Francesca; Zavattari, Patrizia; Scartozzi, Mario; Burgio, Valentina; Ratti, Francesca; Aldrighetti, Luca; Cascinu, Stefano; Casadei-Gardini, Andrea | |
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients | 1-gen-2023 | Rimini, M.; Fabregat-Franco, C.; Persano, M.; Burgio, V.; Bergamo, F.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Rizzato, M.; Nichetti, F.; Lai, E.; Cappetta, A.; Macarulla, T.; Fassan, M.; De Braud, F.; Pretta, A.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A. | |
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions | 1-gen-2022 | Macias, R. I. R.; Cardinale, V.; Kendall, T. J.; Avila, M. A.; Guido, M.; Coulouarn, C.; Braconi, C.; Frampton, A. E.; Bridgewater, J.; Overi, D.; Pereira, S. P.; Rengo, M.; Kather, J. N.; Lamarca, A.; Pedica, F.; Forner, A.; Valle, J. W.; Gaudio, E.; Alvaro, D.; Banales, J. M.; Carpino, G. | |
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection | 1-gen-2022 | Ravaglia, C.; Doglioni, C.; Chilosi, M.; Piciucchi, S.; Dubini, A.; Rossi, G.; Pedica, F.; Puglisi, S.; Donati, L.; Tomassetti, S.; Poletti, V. | |
Clinicopathological features of adenosquamous pancreatic cancer | 1-gen-2011 | Regi, P.; Butturini, G.; Malleo, G.; Pedica, F.; D'Onofrio, M.; Bassi, C. | |
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations | 1-gen-2023 | Ahmed, Naghia; Falcinelli, Francesca; Rimini, Margherita; Burgio, Valentina; Casadei-Gardini, Andrea; Aldrighetti, Luca; Ratti, Francesca; Pedica, Federica | |
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas | 1-gen-2019 | Zaccari, P; Cardinale, V; Severi, C; Pedica, F; Carpino, G; Gaudio, E; Doglioni, C; Petrone, Mc; Alvaro, D; Arcidiacono, P. G.; Capurso, G. | |
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? | 1-gen-2023 | Marino, R; Ratti, F; Della Corte, A; Santangelo, D; Clocchiatti, L; Canevari, C; Magnani, P; Pedica, F; Casadei-Gardini, A; De Cobelli, F; Aldrighetti, L | |
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] | 1-gen-2022 | Rimini, M.; Macarulla, T.; Burgio, V.; Lonardi, S.; Niger, M.; Scartozzi, M.; Rapposelli, I. G.; Aprile, G.; Ratti, F.; Pedica, F.; Verdaguer, H.; Nappo, F.; Nichetti, F.; Lai, E.; Valgiusti, M.; Cappetta, A.; Fabregat-Franco, C.; Fassan, M.; De Braud, F.; Puzzoni, M.; Frassineti, G. L.; Simionato, F.; De Cobelli, F.; Aldrighetti, L.; Fornaro, L.; Cascinu, S.; Casadei-Gardini, A. |